FDA
approval
· 2025-07-10
FDA Approved: MOTEGRITY — Supplemental Application (Takeda Pharmaceuticals America, Inc.)
Summary
The FDA approved a supplemental application for MOTEGRITY (prucalopride) from Takeda Pharmaceuticals America, Inc., indicating an update to the approved labelin…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for MOTEGRITY (PRUCALOPRIDE)